S. 3187 (112th): Food and Drug Administration Safety and Innovation Act

Introduced:

May 15, 2012
112th Congress, 2011–2013

Status:

Enacted — Signed by the President on Jul 9, 2012

This bill was enacted after being signed by the President on July 9, 2012.

Law:

Pub.L. 112-144

Sponsor:

Thomas “Tom” Harkin

Senator from Iowa

Democrat

Text:

Read Text »
Last Updated: Jun 27, 2012
Length: 140 pages

About the bill

Full Title

A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes.

Read CRS Summary >

History

May 15, 2012
 
Introduced

This is the first step in the legislative process.

May 16, 2012
 
Reported by Committee

A committee has issued a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

May 24, 2012
 
Passed Senate

The bill was passed in a vote in the Senate. It goes to the House next.

Jun 20, 2012
 
Passed House with Changes

The House passed the bill with changes not in the Senate version and sent it back to the Senate to approve the changes. The vote was by voice vote so no record of individual votes was made.

Jun 26, 2012
 
Senate Agreed to Changes

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.

Jul 9, 2012
 
Enacted — Signed by the President

The President signed the bill and it became law.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: